Return to Statistics Toolbox

OPLS-DA analysis for Study ST003428

(Analysis AN005629 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.05 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:2 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.05 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:2 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:40 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM rotenone
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA

  logo